APG101 in Glioblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Apogenix GmbH
ClinicalTrials.gov Identifier:
NCT01071837
First received: February 18, 2010
Last updated: March 11, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)